# US 2019/0167983 A1 · Contactless electropermeabilization electrode and method

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2019/0167983 A1
- Document ID: US20190167983A1
- Status: Published application
- Kind: A1
- Application number: 16/272,685
- Filed: 2019-02-11
- Published: 2019-06-06
- Earliest claimed: 2009-04-16
- Assignees: VGX Pharmaceuticals, Inc.
- Applicants: VGX Pharmaceuticals, LLC
- Inventors: Thomas Joseph KARDOS; Stephen Vincent KEMMERRER; Rune KJEKEN; Kate BRODERICK; Jay MCCOY; Michael P. FONS
- Web page: https://patentgrep.com/patent/US20190167983A1

## CPC

- A61N 1/327: {for enhancing the absorption properties of tissue, e.g. by electroporation}
- A61N 1/0416: {Anode and cathode}
- A61N 1/0476: {Array electrodes (including any electrode arrangement with more than one electrode for at least one of the polarities)}
- A61M 2037/0007: {having means for enhancing the permeation of substances through the epidermis, e.g. using suction or depression, electric or magnetic fields, sound waves or chemical agents}
- A61N 1/325: {for iontophoresis, i.e. transfer of media in ionic state by an electromotoric force into the body (electrodes for external use A61N1/0428)}
- A61N: ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY (measurement of bioelectric currents A61B; surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body A61B18/00; anaesthetic apparatus in general A61M; incandescent lamps H01K; infrared radiators for heating H05B)
- A61M: DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY (introducing media into or onto the bodies of animals A61D7/00; means for inserting tampons A61F13/26; devices for administering food or medicines orally A61J; containers for collecting, storing or administering blood or medical fluids A61J1/05); DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY (surgery A61B; chemical aspects of surgical articles A61L); DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR {(Electrotherapy, e.g. producing anaesthesia by the use of alternating or intermittent currents A61N1/36021)}

## Abstract

Devices and methods for delivering an electropermeabilizing pulse of electric energy to a tissue surface to enable delivery into cells in the tissue therapeutic substances. The device incorporates a source capable of generating a sufficient voltage potential to deliver a spark across a gap and delivers same to the tissue surface.

## Claims

### Claim 1

A method of enabling the delivery of therapeutic substances into cells of tissue of a mammal by using a spark electropermeabilizing device to deliver an electropermeabilizing electric voltage potential to the surface of a mammalian tissue, comprising:
generating a voltage potential sufficient to jump a gap of predetermined distance;
delivering said generated voltage potential in the form of a spark that can jump said gap to the surface of the mammalian tissue without causing macroscopic damage to an integrity of the surface of the mammalian tissue; and
delivering the therapeutic substances to cells within the mammalian tissue.

### Claim 2 (depends on 1)

The method of claim 1, wherein the delivering step comprises:
delivering the voltage potential across a spark-gap regulator having a space gap; wherein the spaced gap is the gap of predetermined distance.

### Claim 3 (depends on 1)

The method of claim 1, wherein the generated voltage potential is from 0.9 kV to 109 kV.

### Claim 4 (depends on 1)

The method of claim 1, wherein the delivered voltage potential further comprises a total electric charge of about between 2.8×10E-8 and 2.5×10E-6 Coulombs.

### Claim 5 (depends on 1)

The method of claim 1, wherein the delivered voltage potential imparts a total energy to the surface of a mammalian tissue about between 0.000025 and 0.27 Joules.

### Claim 6 (depends on 1)

The method of claim 1, wherein the delivered voltage potential has a pulse length of about between 5 nanoseconds and 5 microseconds.

### Claim 7 (depends on 1)

The method of claim 1, wherein the delivering step is repeated a multiplicity of times between 2 and 20 pulses.

### Claim 8 (depends on 1)

The method of claim 1, wherein the therapeutic substance comprises a polynucleotide encoding an expressible polypeptide.

### Claim 9 (depends on 1)

The method of claim 1, wherein the therapeutic substance comprises a polypeptide.

### Claim 10 (depends on 1)

The method of claim 1, wherein the energy source of the electric voltage potential is selected from one of a 1, 3, 9 or 12V battery, a piezoelectric crystal, a charged induction coil, a van de Graaff generator, and a charged capacitor.

### Claim 11 (depends on 2)

The method of claim 2, further comprising:
discharging from the electrode directly to the surface of the mammalian tissue.

### Claim 12 (depends on 2)

The method of claim 2, further comprising:
providing the spark-gap regulator having a housing comprising an electrically inert material;
providing a supply electric lead and a receiving electric lead that are each placed within the housing and that are electrically isolated from one another;
providing a space gap between the supply electric lead and the receiving electric lead inside the housing; and
adjusting an atmospheric pressure in the housing to a predetermined value.

### Claim 13 (depends on 12)

The method of claim 12, wherein the space gap has a measurement of between 0.01 cm and 4 cm.
